UA Geneticists Find Causes for Severe Childhood Epilepsies

Posted on Tue/7/MayTue/7/May by AZBio

Using a state-of-the-art DNA sequencing technique, UA researchers have discovered genetic mutations underlying seizure disorders in previously undiagnosed childrenContinue reading→

UA Research Suggests Link Between Elevated Blood Sugar, Alzheimer’s Risk

Posted on Mon/6/MayMon/6/May by AZBio

About 5 percent of men and women, ages 65 to 74, have Alzheimer’s disease, and it is estimated that nearly half of those age 85 and older may have the disease. Among known risks are age and geneticsContinue reading→

Phase III Colon Cancer Prevention Therapy Trial Now Open for Enrollment

Posted on Fri/19/AprilFri/19/April by AZBio

Cancer Prevention Pharmaceuticals, Inc., (CPP) announced today the launch of a Phase III colon cancer prevention trial in collaboration with the National Cancer Institute (NCI) and SWOG, an NCI-supported clinical trials group. The Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES) trial is a Phase III trial testing CPP’s prevention therapy product CPP-1X/sul (eflornithine/sulindac) in 1340 colon cancer survivors—each of whom will receive daily treatment for three years to prevent the recurrence of cancer or high-risk polyps.Continue reading→

Virtual Clinic Showcases New Technology for Teaching Medical Students

Posted on Mon/15/AprilMon/15/April by AZBio

The state-of-the-art center at the UA College of Medicine-Phoenix allows students to develop diagnostic skills and patient care abilitiesContinue reading→